Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8651 to 8672 of 9100 messages
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
DateSubjectAuthorDiscuss
10/12/2020
12:48
I know. Another fully paid up member of the p(r)awn sandwich brigade. The amount of nothing produced by Walbrook, Motif and Peel Hunt has been a collective enigma.
scottdavid70
10/12/2020
11:09
Chris massive disappointment...circled the drain very quickly after getting into bed with Loser Lumsden
scottdavid70
10/12/2020
11:06
Milked it like a Holstein-Friesland Lumsden hasn’t milked something for this long since he was born...
scottdavid70
10/12/2020
10:25
A lot of people said the bod would milk this to the very end knowing their characters.....how right they were! Chris and peel hunt have been a complete waste of space, time and money.....shocker!
chuffer2
10/12/2020
09:06
Iclaprim must have some residual value otherwise the whole development has been for nothing! If we could get some residual value after Hercules are paid then we might finally get something back even if no RTO takes place. Not the best place to be in.....
smcl
10/12/2020
08:37
When is Laureate Lumsdens next appearance on ProActive Investors? I miss his prose and utter hogwash. We are still waiting 18 months after he said the tie up with Lamellar would have some findings ready for investors a few months after signing in May 2019. Utterly shambolic
scottdavid70
09/12/2020
08:15
Feels like the end. Someone on LSE talking about checking inboxes? What’s all that about? I haven’t heard a thing or been sent anything
scottdavid70
08/12/2020
15:27
The radio silence speaks volumes doesn't it? What a disgraceful way to treat their shareholders from whom they were all rewarded handsomely! Are they all of retirement age because this debacle is not going to read well on ones CV is it?
jibba jabber
08/12/2020
09:46
This goose is cooked before the Turkey even is selected this Christmas...
scottdavid70
07/12/2020
18:36
Great trading day for us. Came close to a record breaker. Where's scottdavid, I miss his positivity
standonkin 101
04/12/2020
14:52
Another week of absolutely nothing. In a sense that is an achievement for a BOD that has achieved noting but dilution since 14th February 2019
scottdavid70
04/12/2020
07:52
I see the AMR Fund went very active on social media yesterday maybe they are about to but Iclaprim for a $100 million :-))))) They are investing in biotechs with a innovative novel product that’s post phase I. Must be iclaprim right:-)))))
scottdavid70
04/12/2020
07:50
58 days. They must have some strong hand to be needing this long to negotiate from term sheet to deal. How many genuinely believe that is the case in the basis of what has gone before?
scottdavid70
04/12/2020
07:49
58 days from Term Sheets to now. Are they still active and being negotiated on? They were happy to tell us there were several that had progressed to that stage but When they said that have progressed did they mean they have progressed but by the time of writing the RNS they were no longer active? You can’t believe a word they say here sadly
scottdavid70
03/12/2020
07:14
57 days since the term sheets were agreed - ‘all bases covered’ Graham Lumsden May 2019 So comforting and reassuring those words aren’t they otherwise you think there might not be a deal with his assurance. So far Graham has yet to be wrong...
scottdavid70
02/12/2020
07:57
Had to send this to Walbrook yesterday but no reply as I would like to see how as a PR agency you would spin this into justifying Lumsdens BONUS? Iclaprim didn’t happen as predicted No clinical trials post CRL - just the Phase iii for new trial Route to market for Iclaprim- still hasn’t happened In the market for new antibiotics- didn’t materialise HABP trails - cancelled EMA submission- pulled Lamellar tie up news within months - still no news Nasdaq IPO - two go’s - zero upside only extra regulation costs - delist US Army trials - no news so therefore as of now no benefit So explain how this even remotely A) Keeps you in a job B) puts you in line for a BONUS Nothing as yet. When you read this it probably will take a few days to come up with some imaginative prose to counter the narrative
scottdavid70
02/12/2020
07:44
With the Pfizer vaccine now about to be ruled these Covid therapeutics must be redundant before they were even essential. God speed to the BOD as it’s the only speed they know
scottdavid70
02/12/2020
07:19
Day 55 since term sheets agreed for the mushrooms This is the chapter literally called Fed like Mushrooms Before the final one which is A Grand for Graham as last man out to turn off the lights he deserves more money for his usefulness from start to finish
scottdavid70
01/12/2020
18:42
Yeah sorry to say for holders i can't see anyt5hing coming of this, what a disgrace of a management team. Really they ought to be scrutinised in a court of law, seems to me that they have lied their way through this whole debacle.
jibba jabber
01/12/2020
09:12
Have sent that as an alternative LinkedIn resume for Graham but as yet haven’t seen it supersede his current one
scottdavid70
01/12/2020
08:34
BONUS? Iclaprim didn’t happen as predicted No clinical trials post CRL - just the Phase iii for new trial Route to market for Iclaprim- still hasn’t happened In the market for new antibiotics- didn’t materialise HABP trails - cancelled EMA submission- pulled Lamellar tie up news within months - still no news Nasdaq IPO - two go’s - zero upside only extra regulation costs - delist US Army trials - no news so therefore as of now no benefit So explain how this even remotely A) Keeps you in a job B) puts you in line for a BONUS
scottdavid70
01/12/2020
08:17
Apart from the lack of speed it’s the utter disdain for shareholders who have supported the company. Easy to trot out a few sentences saying they appreciate the support but then their actions shown them up for what they are. The shares aren’t traceable. They won’t even confirm what the patents mean potentially for investors. If the several companies they say were at term sheet stage, does that mean term sheets HAVE reached or HAD reached But the biggest one for me as everyone knows is the BONUS. WTF is that for? It’s is beyond comprehension that Lumsden is in line for a BONUS. The character of the BOD is shot to pieces with that staying in play. Investors nursing losses of over 95% and he is getting a BONUS?? He didn’t even do his job of getting Iclaprim approved but is supposedly getting something called a BONUS for I assume doing something better that he actually failed to do!!! Please explain
scottdavid70
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210225 11:08:34